The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.

MLA

Qi, Xiao-Lan, et al. “The Consequences of Reducing Expression of the Alpha7 Nicotinic Receptor by RNA Interference and of Stimulating Its Activity with an Alpha7 Agonist in SH-SY5Y Cells Indicate That This Receptor Plays a Neuroprotective Role in Connection with the Pathogenesis of Alzheimer’s Disease.” Neurochemistry International, vol. 51, no. 6–7, Nov. 2007, pp. 377–83. EBSCOhost, https://doi.org/10.1016/j.neuint.2007.04.002.

APA

Qi, X.-L., Nordberg, A., Xiu, J., & Guan, Z.-Z. (2007). The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer’s disease. Neurochemistry International, 51(6–7), 377–383. https://doi.org/10.1016/j.neuint.2007.04.002

Chicago

Qi, Xiao-Lan, Agneta Nordberg, Jin Xiu, and Zhi-Zhong Guan. 2007. “The Consequences of Reducing Expression of the Alpha7 Nicotinic Receptor by RNA Interference and of Stimulating Its Activity with an Alpha7 Agonist in SH-SY5Y Cells Indicate That This Receptor Plays a Neuroprotective Role in Connection with the Pathogenesis of Alzheimer’s Disease.” Neurochemistry International 51 (6–7): 377–83. doi:10.1016/j.neuint.2007.04.002.